Publication of the financial results for the 2023-2024 fiscal year and videoconference on Monday, June 10, 2024
June 3, 2024
Previous PostMedincell publishes its consolidated annual financial results
Next PostMedincell’s Partner Teva presented New Data Providing Schizophrenia Treatment Insights into Switching to UZEDY® (risperidone) from Invega Sustenna® (paliperidone palmitate)
